Xarelto (drug)

WASHINGTON (AP) — Federal regulators have denied Johnson & Johnson's request to expand approval of its blood thinner Xarelto (ZAR-el-toh) for a new use to prevent life-threatening blood clots in high-risk patients. J&J said Thursday the Food and...

Ever since the drug warfarin was discovered to be a highly effective anti-clotting agent as well as a good rat poison in the early 1950s, it has been the frontline weapon in preventing stroke among those with atrial fibrillation. But its growing use has...

Cancer didn't stand a chance the first time it bothered Digger Phelps three years ago, and the former Notre Dame men's basketball coach has no desire to let it hang around for an extended stay this time. Disclosing late Thursday that he has bladder...

(Actualiza con detalles; cambia redacción) FRANCFORT, 25 abr (Reuters) - La débil demanda de plásticos y productos químicos de Bayer obligó al grupo diversificado a reducir sus previsiones para su división MaterialScience, eclipsando las mayores...

INGELHEIM, Germany, April 24 (Reuters) - Boehringer Ingelheim said its anti-blood-clotting drug Pradaxa reached blockbuster status in 2012, helping the world's largest unlisted drugmaker to an 11.5 percent rise in sales for last year. Sales of the pill,...

LOS ANGELES (Reuters) - The cost of treating heart disease has become a key factor in decisions by U.S. cardiologists grappling with the nation's No. 1 killer. Record prices for drugs and devices, reduced reimbursement by insurance plans and the...

PARIS (Reuters) - An experimental anti-clotting drug from Bristol-Myers Squibb and Pfizer saved more lives than standard treatment warfarin in a major study, giving it an edge over rivals in an emerging multibillion-dollar market. Although Eliquis will...

ORLANDO, Florida (Reuters) - Cardiologists are not ready to jump to any conclusions about a closely-watched group of new blood thinners and said serious questions about their safety still need to be addressed. Three new medicines that offer potential...